Please login to the form below

Not currently logged in
Email:
Password:

Naxitamab

This page shows the latest Naxitamab news and features for those working in and with pharma, biotech and healthcare.

Y-mAbs files breakthrough neuroblastoma drug in US

Y-mAbs files breakthrough neuroblastoma drug in US

The BLA will cover the use of naxitamab in combination with GM-CSF – a white blood cell stimulating drug – in relapsed/refractory high-risk neuroblastoma patients. ... Y-mAbs reported new results from its main phase 3 naxitamab study at the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...